As indicated below in April 2016 Phosphagenics and Terumo entered into an 18 month arrangement for a propofol injectable development.This currently only leaves about 4 months for this agreement to run.According to Future Market Insights[FMI] propofol accounts for nearly one-third of the global anasthesia market and is expected to expand at CAGR of over 5% through 2025.
"As part of the R&D alliance the companies have also agreed to collaborate on the global development of three additional pharmaceutical products leveraging Phosphagenics’ proprietary TPM® technology: a TPM®/Propofol injection building on the prototype already developed at Phosphagenics and two additional novel TPM® containing pharmaceutical products"
Kens
-
- There are more pages in this discussion • 74 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
-0.001(10.0%) |
Mkt cap ! $14.28M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $2.55K | 511.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 26 | 18250625 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 27692966 | 23 |
View Market Depth
| Last trade - 12.03pm 25/07/2025 (20 minute delay) ? |
| AVE (ASX) Chart |